24Mar
FAQs: COVID-19 – Considerations in M&A Transactions
As the Coronavirus (COVID-19) outbreak continues to spread across the globe, merger and acquisition transaction participants need to consider the impact it is having on M&A transactions both in terms of process and timeline as well as in terms of...
By:
BakerHostetler
Related
On August 20, 2019, the Ninth Circuit dodged answering the question of whether morbid obesity is a d...
Read More >
As you’ll recall from our extensive coverage of the EEO-1 pay data collection saga (which we previo...
Read More >
In light of the developing COVID-19 pandemic, the Federal Trade Commission’s Premerger Notification...
Read More >
In recent years, healthcare-focused private equity firms and start-ups are looking to minimize risk ...
Read More >
Our October update considers recent developments in employment law, including cases on the whistlebl...
Read More >
The scope of Dynamex is still unknown. The California Legislature and the U.S. Court of Appeals for...
Read More >